These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 10924919)

  • 1. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
    Lockhart B; Iop F; Closier M; Lestage P
    Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
    Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
    Gemignani A; Marchese S; Fontana G; Raiteri M
    Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices.
    Cowen MS; Beart PM
    Br J Pharmacol; 1998 Feb; 123(3):473-80. PubMed ID: 9504388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
    Patel DR; Young AM; Croucher MJ
    Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA and AMPA receptors evoke transmitter release from noradrenergic axon terminals in the rat spinal cord.
    Sundström E; Holmberg L; Souverbie F
    Neurochem Res; 1998 Dec; 23(12):1501-7. PubMed ID: 9821153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclothiazide selectively potentiates AMPA- and kainate-induced [3H]norepinephrine release from rat hippocampal slices.
    Desai MA; Burnett JP; Schoepp DD
    J Neurochem; 1994 Jul; 63(1):231-7. PubMed ID: 7515944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
    Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M
    J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive release of [3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists.
    Nakai T; Milusheva E; Baranyi M; Uchihashi Y; Satoh T; Vizi ES
    Eur J Pharmacol; 1999 Feb; 366(2-3):143-50. PubMed ID: 10082194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
    Bourasset F; Bernard K; Muñoz C; Genissel P; Scherrmann JM
    Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
    Malva JO; Carvalho AP; Carvalho CM
    Br J Pharmacol; 1994 Dec; 113(4):1439-47. PubMed ID: 7534187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.
    Ohno K; Okada M; Tsutsumi R; Matsumoto N; Yamaguchi T
    Neurochem Int; 1998 Mar; 32(3):265-71. PubMed ID: 9587920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
    Desai MA; Burnett JP; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG; Gruner R; Rozental J
    Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
    Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
    J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of presynaptic AMPA receptors in the control of neuronal glutamate release in the rat forebrain.
    Patel DR; Croucher MJ
    Eur J Pharmacol; 1997 Aug; 332(2):143-51. PubMed ID: 9286615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells.
    Kapus G; Bódi I; Pataki A; Gueritaud J; Székely JI; Tarnawa I
    Eur J Pharmacol; 2000 May; 397(1):43-7. PubMed ID: 10844097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of AMPA-induced biting behaviour in mice.
    Brambilla A; Prudentino A; Grippa N; Borsini F
    Eur J Pharmacol; 1996 Jun; 305(1-3):115-7. PubMed ID: 8813540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.